MATRISTEM MICROMATRIX MM0100F

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2016-10-27 for MATRISTEM MICROMATRIX MM0100F manufactured by Acell, Inc.

Event Text Entries

[58502112] A comprehensive investigation was conducted on discovery. Treating physician was contacted and confirmed the complainant underwent a hair restoration procedure wherein a suspension of prp and micromatrix was injected into the scalp. The patient was treated with lidocaine injected into the scalp just prior to the procedure. Physician stated the patient had swelling at the injection site that lasted longer than normal. However, he believed the headaches are the patient's main issue. Additionally, patient stated she declined customary nsaids given at the completion of the procedure. Physician stated he has used acell micromatrix in the same manner for 5 years and has not had other patients who have experienced similar issues. According to the physician, the patient did not have any signs of infection on the scalp and did not develop a fever. The physician also stated that he has used the same lot of micromatrix on several other patients with no issues. He is working with the patient's primary care physician to determine a path forward. A review of the manufacturing records for the lot identified no substantial deviation and demonstrated the product was manufactured and distributed in compliance with fda, state, local, and manufacturer operating procedures. There was no report of device failure from the treating physician at any time. This mdr has been filed out of an abundance of caution.
Patient Sequence No: 1, Text Type: N, H10


[58502113] Acell received a report from a patient who claimed she developed swelling and headaches after micromatrix reconstituted with platelet rich plasma (prp) was injected into the scalp by her physician. The patient was also injected with lidocaine into the scalp just prior to the micromatrix suspension treatment. Four days later, the complainant alleged she developed swelling, severe headaches with dizziness, and a bulging vein. She stated swelling lasted for approximately 3 weeks and took a month to fully resolve. Patient claimed she has been in contact with the treating physician and her primary care physician to try to treat and eliminate the persistent headaches.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005920706-2016-00006
MDR Report Key6060035
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2016-10-27
Date of Report2016-09-30
Date of Event2016-08-24
Date Mfgr Received2016-09-30
Device Manufacturer Date2016-03-22
Date Added to Maude2016-10-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. BARRY BRAINARD
Manufacturer Street6640 ELI WHITNEY DR.
Manufacturer CityCOLUMBIA MD 21046
Manufacturer CountryUS
Manufacturer Postal21046
Manufacturer Phone8034870493
Manufacturer G1ACELL, INC
Manufacturer Street6640 ELI WHITNEY DR.
Manufacturer CityCOLUMBIA MD 21046
Manufacturer CountryUS
Manufacturer Postal Code21046
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMATRISTEM MICROMATRIX
Generic NamePOWDER WOUND DRESSING
Product CodeKGN
Date Received2016-10-27
Model NumberMM0100F
Lot NumberLP5917-11
Device Expiration Date2018-03-31
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerACELL, INC
Manufacturer Address6640 ELI WHITNEY DR. COLUMBIA MD 21046 US 21046


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other 2016-10-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.